Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation.
about
Retigabine: has the orphan found a home?Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.Epilepsy: The future scenario.AAN/AES guidelines on use of new AEDSEfficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.A Greater Role for Surgical Treatment of Epilepsy: Why and When?Levetiracetam in pediatrics.Hallucination in a seizure patient using levetiracetam: a case report.Neurostimulation-past, present, and beyond.Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?Efficacy and tolerability of pregabalin in partial epilepsy.Pattern of adverse events of antiepileptic drugs: results of the aESCAPE study in Poland.Second-generation antiepileptic medications in children: efficacy and cognitive effects.Adverse effects of antiepileptic drugs: a brief overview of important issues.Occipital nerve stimulation for chronic migraine: a randomized trial on subthreshold stimulation.Outcome measurement after vagal nerve stimulation therapy: proposal of a new classification.Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.Epileptic Seizures are Reduced by Autonomic Biofeedback Therapy Through Enhancement of Fronto-limbic Connectivity: A Controlled Trial and Neuroimaging Study.Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathies.Guidelines--are they useful?
P2860
Q24685444-312F3D7F-0AA7-413C-B014-DE55668A243EQ33395054-3FCDB63A-3E9D-4F98-9194-55721BBA8B80Q33810221-B0D30D74-E3FB-4BFF-BA1E-4D312B90C36EQ33899368-265F00A0-FCEA-433D-A1D4-40F0E945E053Q34652020-7E86F47C-115C-461B-9A7A-61A5CB4F3A7FQ35537454-128709DC-58BC-4D0C-8147-74A068506FBCQ36081844-E9AEA164-AF1A-4BE3-941C-E8D20DEA809AQ36125182-5C35075A-FEFC-4B96-86E2-1392573E6292Q36352103-7529C198-9496-439C-AF24-18F1486BA0D4Q36566726-3D18294F-6EC6-497C-961C-66C5C525F9ABQ37203346-3531C9D6-56CB-4AB4-9622-250C43F7C7F8Q37321910-268AB802-4102-446E-885E-E0C3A0E7CA83Q37610152-48386201-0135-47FC-9776-19CE4994A0F0Q37762256-602F0923-6E8F-4B91-8169-4F338B998299Q39207328-88C35E40-F711-4E7E-8FE6-8D81CD3C12DDQ40242991-AE71B375-684A-4551-9D83-F585E037A365Q42678199-3CF81EDA-28AC-4E31-AFE0-7E44DAF1F1CBQ47183008-6602E216-00FC-4882-BFF8-56C327303F54Q48774739-163D6D37-B50C-441F-A238-99CC0F2C62B3Q53011768-0A8B4D1C-5464-4662-80EE-34F429F10018
P2860
Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Review of treatment options fo ...... s and vagal nerve stimulation.
@ast
Review of treatment options fo ...... s and vagal nerve stimulation.
@en
Review of treatment options fo ...... s and vagal nerve stimulation.
@nl
type
label
Review of treatment options fo ...... s and vagal nerve stimulation.
@ast
Review of treatment options fo ...... s and vagal nerve stimulation.
@en
Review of treatment options fo ...... s and vagal nerve stimulation.
@nl
prefLabel
Review of treatment options fo ...... s and vagal nerve stimulation.
@ast
Review of treatment options fo ...... s and vagal nerve stimulation.
@en
Review of treatment options fo ...... s and vagal nerve stimulation.
@nl
P2093
P1433
P1476
Review of treatment options fo ...... s and vagal nerve stimulation.
@en
P2093
Ben Menachem E
P356
10.1016/S0920-1211(01)00286-8
P577
2001-11-01T00:00:00Z